2m 2m 2m 2m 2m 2m 2m
Xencor (XNCR)
NASDAQ
$25.97+$0.81 (+3.23%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.9BMarket Cap
- 89.32%1-Year Change
- BiotechnologyIndustry
Xencor (XNCR)
$25.97+$0.81 (+3.23%)
XNCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.16 | ||
Change | +$0.22 (+0.88%) | ||
Open | $25.40 | ||
High | $25.50 | ||
Low | $24.42 | ||
Previous Close | $24.94 | ||
Volume | 1,479,582 | ||
30-Day Average Volume | 1,354,177 | ||
1-Week Change | 7.57% | ||
1-Month Change | 0.52% | ||
1-Year Change | 89.32% | ||
3-Year Change | 38.32% | ||
5-Year Change | -35.02% | ||
Fundamentals | |||
Shares Outstanding | 74.4M | ||
Total Assets | $725.0M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $51.2M | ||
Net Income | -$21.7M | ||
Free Cash Flow | -$56.2M | ||
EBIT | -$21.9M | ||
EBITDA | -$19.5M | ||
Net Working Capital | $441.3M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -99 | ||
Enterprise Value/Revenue | 38 | ||
P/B | 4 | ||
P/E | -87 | ||
PEG | -1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue